A 45-year-old with type 2 diabetes and A1C 8.6% has established ASCVD. eGFR 70 mL/min/1.73 m². He takes metformin 1,000 mg BID. According to current s...

Question

A 45-year-old with type 2 diabetes and A1C 8.6% has established ASCVD. eGFR 70 mL/min/1.73 m². He takes metformin 1,000 mg BID. According to current standards, which agent should be prioritized next for cardiovascular risk reduction?

Accepted Answer

GLP-1 receptor agonist with proven CV benefit

Answer

DPP-4 inhibitor

Answer

Sulfonylurea

Answer

Basal NPH insulin

Answer

Thiazolidinedione

us-abim MCQ (SBA): Type 2 Diabetes-CV Risk

A 45-year-old with type 2 diabetes and A1C 8.6% has established ASCVD. eGFR 70 mL/min/1.73 m². He takes metformin 1,000 mg BID. According to current standards, which agent should be prioritized next for cardiovascular risk reduction?